NCT00097708

Experimental Medication For the Treatment of Generalized Anxiety Disorder

A Double-Blind, Placebo Controlled Trial of an Experimental Medication For the Treatment of Generalized Anxiety Disorder

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 511 (actual)
• Sponsor: Jazz Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.

Detailed description

Protocol 04-001-01 The primary objective of the study is to assess, under controlled conditions, the safety and efficacy of an experimental anti-anxiety medication relative to placebo in subjects with generalized anxiety disorder (GAD). The secondary objective of the study is to study algorithms for discontinuation of an experimental anti-anxiety medication. Recruiting: Participants are currently being recruited and enrolled.

Conditions

• Anxiety Disorder

Interventions

Type	Name	Description
DRUG	experimental anti-anxiety drug

Timeline

• Start date: 2004-11-01
• Completion: 2005-12-01
• First posted: 2004-11-30
• Last updated: 2014-10-03
• Results posted: 2014-10-03

Locations

50 sites across 1 country: United States